124 related articles for article (PubMed ID: 38661516)
1. The emergence of tumor-initiating cells in an advanced hypopharyngeal tumor model exhibits enhanced angiogenesis and nuclear factor erythroid 2-related factor 2 associated antioxidant effects.
Lin MY; Wang CY; Chan YH; Su SP; Chiang HK; Yang MH; Lee YJ
Antioxid Redox Signal; 2024 Apr; ():. PubMed ID: 38661516
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus-Mediated Short Hairpin RNA for Follistatin Downregulation Suppresses Tumor Progression in Hypopharyngeal Carcinoma.
Ge L; Liu SF
Curr Med Sci; 2022 Aug; 42(4):832-840. PubMed ID: 35864413
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of microRNA‑194‑5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway.
Xu S; Hui L; Yang N; Wang Y; Zhao N; Jiang XJ
Int J Oncol; 2019 Apr; 54(4):1245-1255. PubMed ID: 30720112
[TBL] [Abstract][Full Text] [Related]
4. Tunicamycin-induced endoplasmic reticulum stress inhibits chemoresistance of FaDu hypopharyngeal carcinoma cells in 3D collagen I cultures and in vivo.
Gu C; Zhang Y; Chen D; Liu H; Mi K
Exp Cell Res; 2021 Aug; 405(2):112725. PubMed ID: 34224701
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Calcium-Binding Protein S100A9 Inhibits Hypopharyngeal Cancer Cell Proliferation and Invasion Ability Through Inactivation of NF-κB Signaling.
Wu P; Quan H; Kang J; He J; Luo S; Xie C; Xu J; Tang Y; Zhao S
Oncol Res; 2017 Nov; 25(9):1479-1488. PubMed ID: 28276321
[TBL] [Abstract][Full Text] [Related]
6. (+)-Usnic acid modulates the Nrf2-ARE pathway in FaDu hypopharyngeal carcinoma cells.
Krajka-Kuźniak V; Paluszczak J; Kleszcz R; Baer-Dubowska W
Mol Cell Biochem; 2021 Jun; 476(6):2539-2549. PubMed ID: 33635505
[TBL] [Abstract][Full Text] [Related]
7. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for hypoxic preconditioning-mediated delayed cardioprotection.
Huang XS; Chen HP; Yu HH; Yan YF; Liao ZP; Huang QR
Mol Cell Biochem; 2014 Jan; 385(1-2):33-41. PubMed ID: 24048861
[TBL] [Abstract][Full Text] [Related]
8. Metformin Suppresses Hypopharyngeal Cancer Growth by Epigenetically Silencing Long Non-coding RNA SNHG7 in FaDu Cells.
Wu P; Tang Y; Fang X; Xie C; Zeng J; Wang W; Zhao S
Front Pharmacol; 2019; 10():143. PubMed ID: 30853913
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-tumor activity of Coenzyme Q
Yang HL; Chiu LW; Lin YA; Pandey S; Vadivalagan C; Liao JW; Gowrisankar YV; Chen HJ; Lin HY; Hseu YC
Toxicol Appl Pharmacol; 2023 Apr; 465():116453. PubMed ID: 36914119
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 Mediates the Delayed Cardioprotection of Hypoxic Preconditioning Through Activation of Nrf2 and Subsequent Upregulation of Antioxidative Enzymes.
Yan YF; Chen HP; Huang XS; Qiu LY; Liao ZP; Huang QR
J Cardiovasc Pharmacol; 2015 Aug; 66(2):148-58. PubMed ID: 25915512
[TBL] [Abstract][Full Text] [Related]
11. Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma.
Gao Q; Liu HT; Xu YQ; Zhang L; Liu YR; Ren Q; Sheng JP; Zhang ZX
Cancer Cell Int; 2021 Oct; 21(1):584. PubMed ID: 34717645
[TBL] [Abstract][Full Text] [Related]
12. The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts.
Fliedner FP; Hansen AE; Jørgensen JT; Kjær A
BMC Med Imaging; 2016 Jan; 16():5. PubMed ID: 26762341
[TBL] [Abstract][Full Text] [Related]
13. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer.
Huang G; Pan ST
Oxid Med Cell Longev; 2020; 2020():5047987. PubMed ID: 32774675
[TBL] [Abstract][Full Text] [Related]
14. Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.
Messier EM; Bahmed K; Tuder RM; Chu HW; Bowler RP; Kosmider B
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559007
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response.
Naumann FV; Kaanders JHAM; Peeters WJM; Adema GJ; Sweep FCGJ; Bussink J; Span PN
Clin Transl Radiat Oncol; 2024 Mar; 45():100726. PubMed ID: 38292333
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation.
Bellanti F; di Bello G; Iannelli G; Pannone G; Pedicillo MC; Boulter L; Lu WY; Tamborra R; Villani R; Vendemiale G; Forbes SJ; Serviddio G
NPJ Regen Med; 2021 May; 6(1):28. PubMed ID: 34039998
[TBL] [Abstract][Full Text] [Related]
17. c-Jun and Camk2a contribute to the drug resistance of induction docetaxel/cisplatin/5-fluorouracil in hypopharyngeal carcinoma.
Liu S; Lian M; Fang J; Zhai J; Shen X; Wang R
Int J Clin Exp Pathol; 2018; 11(9):4605-4613. PubMed ID: 31949859
[TBL] [Abstract][Full Text] [Related]
18. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.
Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3.
Lu YJ; Deng YT; Ko HH; Peng HH; Lee HC; Kuo MY; Cheng SJ
Cancer Sci; 2023 Oct; 114(10):3957-3971. PubMed ID: 37496288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
